
FTSE 100 opens a touch higher as US trade war concerns rekindle
Share this:

FTSE 100 opened up 0.1% at 7,798.15 despite a stronger close in the US markets Wednesday on renewed concerns over a US trade war and ahead of UK retail data.
In the US President Donald Trump initiated an enquiry into car imports into the US which could eventually see tariffs being introduced which would affect European car imports.
In Asian, the Nikkei 225 closed down 1.1% at 22,437.01 while the Hang Seng was flat at 30,671.63.
Ahead of the retail data the pound traded a touch higher against the dollar, up 0.15% at 1.3371, but it weakened against the euro by 0.11% to 1.1399.
Mediclinic International lead the fallers on opening, dropping 5.36% to 642.80 as the company reported a full-year net loss caused by impairment charges on its property in Switzerland and a separate impairment charge against Spire Healthcare in which Mediclinic holds a nearly 30% stake. The company’s pretax profit was down to £479 million from a £307 million profit last year.
Kingfisher shares were also under pressure in early trade and fell 2.13% to 289.10. The home improvement retailer’s sales fell 4% in the first quarter as bad weather earlier in the year impacted footfall from UK customers. The company, the owner of B&Q in the U.K. and Castorama in France, has started its next set of buybacks and will purchase a total of £50 million shares.
Daily Mail and General Trust shares were also among the fallers this morning despite good results where the company said that its pretax profit in the first half of this year doubled, boosted by stronger business-to-business sales. However, overall revenue fell 6.1% to £745.8 million and the board decided against paying out an interim dividend of 7.1 pence a share. Shares fell 2.2% after the company’s earnings report.
Latest market news
View more newsOpen an account today
Experience award-winning platforms with fast and secure execution.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.

EUR/USD Analysis: U.S. Inflation Data Keeps Pressure on the Euro
The trading week continues to unfold and the latest session has once again highlighted weakness around the euro against the U.S. dollar. EUR/USD is down nearly 0.3%, reflecting that the European currency continues to struggle to sustain a consistent recovery in the short term.

EUR/USD Forecast: Euro Under Pressure After Strong NFP Data
As the trading week comes to an end, the euro has once again struggled to sustain a meaningful recovery against the U.S. dollar, highlighting renewed weakness within EUR/USD price action. During the final trading session of the week, the pair declined nearly 0.7%, reflecting that confidence around the European currency remains limited in the short term.

EUR/USD Analysis: Euro Confidence Remains Limited After the ECB
The trading week is approaching its end and, for now, a neutral tone continues to dominate the euro's short-term price action. EUR/USD has recorded a move of only around -0.15% during the week, highlighting the pair's inability to establish a clear direction in favor of either the euro or the U.S. dollar.
From time to time, StoneX Financial Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.






